Thrombosis and Haemostasis

LinksSchließen

Referenz

Perera V, Luettgen JM, Wang Z. , et al.
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.

Br J Clin Pharmacol 2018;
84 (05) 876-887

Bibliographische Angaben herunterladen

Aufrufen in: